REQUEST A DEMO
Total
USD $0.00
Search more companies

Revolut Rx S.R.O. (Czech Republic)

Main Activities: All Other Miscellaneous Manufacturing
Full name: Revolut Rx S.R.O. Profile Updated: November 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Revolut Rx S.R.O. is an enterprise in Czech Republic, with the main office in Brno. It operates in the All Other Miscellaneous Manufacturing sector. It was incorporated on November 15, 2018. There are currently 10 - 19 (2024) people employed by Revolut Rx S.R.O.. From the latest financial highlights, Revolut Rx S.R.O. reported a net sales revenue increase of 18.72% in 2023. Its’ total assets recorded a growth of 55.88%. Revolut Rx S.R.O.’s net profit margin increased by 6.44% in 2023.

Headquarters
Jarni 1116/50
Brno; Jihomoravsky; Postal Code: 61400

Contact Details: Purchase the Revolut Rx S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Revolut Rx S.R.O. report to view the information.
Outstanding Shares:
Purchase the Revolut Rx S.R.O. report to view the information.
Registered Capital:
Purchase the Revolut Rx S.R.O. report to view the information.
Incorporation Date:
November 15, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Revolut Rx S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
18.72%
Total operating revenue
18.98%
Operating profit (EBIT)
571.13%
Net Profit (Loss) for the Period
1198.15%
Total assets
55.88%
Total equity
97.09%
Operating Profit Margin (ROS)
7.93%
Net Profit Margin
6.44%
Return on Equity (ROE)
41.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?